Obstetrics & Gynecology (journal)

Adventist HealthCare Opens Ambulatory Surgery Center at National Harbor

Retrieved on: 
Tuesday, July 11, 2023
Travel, Adventist HealthCare, Interventional cardiology, Ophthalmology, Interventional radiology, Obstetrics & Gynecology (journal), Aneurysm, Adventism, University of Maryland Baltimore Washington Medical Center, County, Ear, Behavior, National Harbor, Maryland, Stroke, General surgery, Blood pressure, Outpatient surgery, Ambulatory Surgery Center Association, AHC, Health, Nursing, Hospital, Gastroenterology

NATIONAL HARBOR, Md., July 11, 2023 /PRNewswire/ -- Adventist HealthCare recently opened its new state-of-the-art Ambulatory Surgery Center located at National Harbor.

Key Points: 
  • NATIONAL HARBOR, Md., July 11, 2023 /PRNewswire/ -- Adventist HealthCare recently opened its new state-of-the-art Ambulatory Surgery Center located at National Harbor.
  • "I'm excited to be a part of this push to improve care in the community," said Dr. Carlin Williams, Director of Vascular Surgery at Adventist HealthCare Fort Washington Medical Center and Vice President of the Adventist HealthCare Ambulatory Surgery Center Governing Board.
  • In addition, the center at National Harbor is equipped to practice a variety of specialties: Bariatric, Ear, Nose, and Throat, Gastroenterology, General Surgery, Interventional Cardiology, Interventional Radiology, Obstetrics/Gynecology, Ophthalmology, Orthopedic/Podiatry, Pain/Spine, Urology, and more.
  • The Ambulatory Surgery Center will serve as a link between nearby Adventist HealthCare Fort Washington Medical Center and its new primary care facility, located just minutes from each other.

High demand for Portugal's sustainable homes

Retrieved on: 
Saturday, October 22, 2022
Pressure, Statistics, SROI, Union, Construction, City, Government, Portugal Golden Visa, Carbon footprint, Housing, European Investment Bank, Carbon, Recycling, United Nations Research Institute for Social Development, WhatsApp, Investment, EUR, ROI, EB-5 visa, Euro, 971, Building material, World Green Building Council, Legislation, Awareness, Blog, Climate change, Environment, Sintra, Green growth, Obstetrics & Gynecology (journal), COVID-19, D7, Renewable energy

Conscious citizens with a passion for recycling and awareness of climate change demonstrate Portugal's dedication to sustainable living.

Key Points: 
  • Conscious citizens with a passion for recycling and awareness of climate change demonstrate Portugal's dedication to sustainable living.
  • The future of real estate emphasizes sustainability, as an increasing number of investors are hunting for sustainable properties.
  • UK's Green Journal states that 83% of investors in Portugal foresee a rise in demand from tenants for sustainable properties.
  • Since greener materials and construction methods are nowadays more available and less costly, the development of sustainable properties is more viable.

High demand for Portugal's sustainable homes

Retrieved on: 
Saturday, October 22, 2022
Pressure, Statistics, SROI, Union, Construction, City, Government, Portugal Golden Visa, Carbon footprint, Housing, European Investment Bank, Carbon, Recycling, United Nations Research Institute for Social Development, WhatsApp, Investment, EUR, ROI, EB-5 visa, Euro, 971, Building material, World Green Building Council, Legislation, Awareness, Blog, Climate change, Environment, Sintra, Green growth, Obstetrics & Gynecology (journal), COVID-19, D7, Renewable energy

Conscious citizens with a passion for recycling and awareness of climate change demonstrate Portugal's dedication to sustainable living.

Key Points: 
  • Conscious citizens with a passion for recycling and awareness of climate change demonstrate Portugal's dedication to sustainable living.
  • The future of real estate emphasizes sustainability, as an increasing number of investors are hunting for sustainable properties.
  • UK's Green Journal states that 83% of investors in Portugal foresee a rise in demand from tenants for sustainable properties.
  • Since greener materials and construction methods are nowadays more available and less costly, the development of sustainable properties is more viable.

Dr. Alan Copperman Recognized as a Notable Health Care Leader by Crain's New York Business 2022

Retrieved on: 
Monday, August 22, 2022
Icahn School of Medicine at Mount Sinai, COVID-19, Fertility preservation, Patient, Reproductive medicine, CEO, Division, Health minister, Obstetrics & Gynecology (journal), Vaccination, Research, Genetics, Infertility, Health (magazine), Physician, Yale New Haven Hospital, RMA, IVF, Multimedia, Evidence-Based Veterinary Medicine Association, Medical director, Fertility, Obstetrics and gynaecology, U.S. News & World Report, Genomics, Industry, Growth, Health, CBS, Pharmaceutical industry, Birth control, Obstetrics, New York (magazine), The New York Times, Gynaecology

NEW YORK, Aug. 22, 2022 /PRNewswire/ -- Reproductive Medicine Associates of New York (RMA of New York) is proud to announce that Dr. Alan Copperman has been named one of Crain's New York Business 2022 Notable Health Care Leaders for his extensive contributions to the field of reproductive medicine.

Key Points: 
  • NEW YORK, Aug. 22, 2022 /PRNewswire/ -- Reproductive Medicine Associates of New York (RMA of New York) is proud to announce that Dr. Alan Copperman has been named one of Crain's New York Business 2022 Notable Health Care Leaders for his extensive contributions to the field of reproductive medicine.
  • As a leader in the field, Dr. Copperman is widely recognized for prioritizing research and innovation to improve patient outcomes.
  • Dr. Copperman's recognition from Crain's comes at a particularly notable juncture in the delivery of reproductive health services in the United States.
  • For more information about Crain's New York Business 2022 Notable Health Care Leaders, visit www.crainsnewyork.com .

Published studies find low documented adherence to guideline-based care for female urinary incontinence

Retrieved on: 
Friday, July 22, 2022
Diagnosis, Obstetrics & Gynecology (journal), Instagram, Use, UI, Adult, SUFU, Cough, LinkedIn, American Urological Association, American College of Obstetricians and Gynecologists, AUA, American College, Obstetrics, Smartphone, Research, Woman, PFMT, Solution, Pelvic floor, Medical Affairs Bureau, Society, Urinary incontinence, Doctor of Pharmacy, All rights reserved, Storey, Engineering, Physician, Overactive bladder, Twitter, Female, ACOG, Sexual dysfunction, Health, Femtech, Quality of life, PDT, FDA, DPT, MUI, FI, Exertion, SUI, Sneeze, Feces, Time, MPH, Urine, Hotel manager, Rehabilitation, Physical, Movement, Mental health, Senior, Patient, PT, Medical device, Medical imaging, Health insurance, Birth control, Gynaecology, Kegel exercise, Gynaecology, Facebook, Urodynamic testing

BOSTON, July 22, 2022 /PRNewswire/ -- Renovia Inc. (Renovia), a developer of non-surgical treatments for female pelvic floor disorders and an advocate for women's health, announced today that Neurourology and Urodynamics published two studies demonstrating low rates of documented adherence to treatment guidelines for female urinary incontinence (UI) care for women and the effect on payer costs. One study showed significantly higher costs for payers in the two years following diagnosis for women whose treatment claims did not align with published guidelines for female UI. A second study showed very low use of physical therapy (PT) for UI, a discipline commonly engaged in first-line care for UI.

Key Points: 
  • BOSTON, July 22, 2022 /PRNewswire/ -- Renovia Inc. (Renovia), a developer of non-surgical treatments for female pelvic floor disorders and an advocate for women's health, announced today that Neurourology and Urodynamics published two studies demonstrating low rates of documented adherence to treatment guidelines for female urinary incontinence (UI) care for women and the effect on payer costs.
  • A second study showed very low use of physical therapy (PT) for UI, a discipline commonly engaged in first-line care for UI.
  • Numerous studies show PFMT isan effective treatment for urinary incontinence and that PFMT, commonly referred to as Kegels, is challenging for women to implement effectively on their own.
  • The study determined that documented care not sequenced in adherence to guidelines increasedpayers' cost burden.

Renovia receives FDA clearance for leva® Pelvic Health System as first-line treatment for chronic fecal incontinence

Retrieved on: 
Thursday, July 7, 2022
Patient, Embarrassment, Food, Doctor of Philosophy, Social isolation, Obstetrics & Gynecology (journal), Regulation of food and dietary supplements by the U.S. Food and Drug Administration, Urinary incontinence, FDA, Movement, MMHC, Leva, Female, Vagina, Woman, Sexual dysfunction, Birmingham, Overactive bladder, Instagram, Associate, Twitter, Exercise intolerance, Research, LinkedIn, Feces, Associate Director of National Intelligence and Chief Information Officer, PFMT, FI, Fecal incontinence, Health, Use, Reproductive health, Financial endowment, Surgery, A Call for Unity, PDT, UAB, Rectum, Professor, Depression, Rehabilitation, Risk, UI, University, Pelvic floor, All rights reserved, Femtech, Vanderbilt University Medical Center, Storey, Pharmaceutical industry, Birth control, Urology, Gynaecology, Obstetrics, Facebook, MD

BOSTON, July 7, 2022 /PRNewswire/ -- Renovia Inc. ("Renovia"), a developer of non-surgical, treatments for female pelvic floor disorders and an advocate for women's health, announced today that the U.S. Food and Drug Administration (FDA) has cleared its leva® Pelvic Health System for the first-line treatment of chronic fecal incontinence (FI) in women. The decision follows the grant of Breakthrough Device Designation by FDA in October 2021. leva had previously been cleared by FDA to treat stress, mixed and mild-to-moderate urinary incontinence (UI) in women. The new indication makes first-line, at-home treatment for FI, also called accidental bowel leakage, available to the over 12 million U.S. women who suffer from the debilitating and progressive condition.

Key Points: 
  • leva is a prescription digital therapeutic (PDT) that guides a woman through pelvic floor muscle training (PFMT).
  • In November 2019, leva was FDA cleared for the treatment of stress, mixed and mild to moderate urgency urinary incontinence (including overactive bladder) in women.
  • The leva Pelvic Health System offers a novel, non-invasive, medication-free way for women to train and strengthen their pelvic floor musclesat home in just five minutes a dayto treat urinary incontinence (UI) and chronic fecal incontinence (FI).
  • Renovia Inc. and leva are trademarks or registered trademarks of Renovia Inc. in the United States and other countries.

Published health economics study shows improved treatment for female urinary incontinence may have positive effect on patient outcomes and healthcare costs

Retrieved on: 
Tuesday, June 21, 2022
PT, Rehabilitation, Cough, Pelvic floor, Smartphone, LinkedIn, Obstetrics, Urine, University, Keck School of Medicine of USC, Health, MUI, Associate, Urinary incontinence, Division, Obstetrics & Gynecology (journal), Incontinence, Therapy, Female, UI, Use, Storey, PDT, Sneeze, Twitter, Movement, PFMT, FDA, Urogynecology, All rights reserved, Medical Affairs Bureau, Sexual dysfunction, Exertion, SUI, Adult, Patient, Multimedia, Instagram, Woman, Safety, Research, Kegel exercise, Overactive bladder, Femtech, Pharmaceutical industry, Health insurance, Birth control, Medical imaging, Gynaecology, Urodynamic testing, Medicine, Facebook

BOSTON, June 21, 2022 /PRNewswire/ -- Renovia Inc. (Renovia), a women-led company that develops digital therapeutics for female pelvic floor disorders, announced today that a recent peer-reviewed, published study showed that women with stress urinary incontinence (SUI) and mixed urinary incontinence (MUI) consume significantly more medical resources and incur higher costs to payers, compared to women without SUI/MUI.  The study was published in Neurourology and Urodynamics, the official journal of the Society of Urodynamics and Female Pelvic Medicine & Urogenital Reconstruction.

Key Points: 
  • The study was published in Neurourology and Urodynamics , the official journal of the Society of Urodynamics and Female Pelvic Medicine & Urogenital Reconstruction.
  • The study, "Healthcare Resource Use and Cost Burden of Urinary Incontinence to United States Payers," assessed healthcare resource utilization and costs for female patients diagnosed with stress or mixed urinary incontinence (SUI/MUI) compared to a 1:1 matched cohort of patients without SUI/MUI.
  • Urinary incontinence (UI) is a highly prevalent health condition experienced by over 60% of adult women.
  • Multiple studies show that Pelvic Floor Muscle Training (PFMT), commonly referred to as Kegel exercises, can offer effective, first-line treatment for urinary incontinence.

Renovia debuts "Stronger Women" campaign at annual gathering of women's health care leaders

Retrieved on: 
Friday, May 6, 2022
PDT, Rehabilitation, Loneliness, American College, University, University of New Mexico, Instagram, Twitter, Femtech, Woman, ACOG, Smartphone, Physician, Massachusetts General Hospital, Shame, Research, PFMT, Use, Storey, Patient, Sexual dysfunction, ACSM, Obstetrics & Gynecology (journal), University of Alabama, Kegel exercise, FDA, Urinary incontinence, Therapy, M.D, Overactive bladder, Adult, Health, Randomized controlled trial, Movement, LinkedIn, Female, UI, Harvard Medical School, Science, Pelvic floor, CEO, SAN, Obstetrics, Obstetrics and gynaecology, All rights reserved, American College of Obstetricians and Gynecologists, Taboo, Digital, Birth control, Pharmaceutical industry, Gynaecology, Facebook

SAN DIEGO, May 6, 2022 /PRNewswire/ -- ACOG Annual Meeting — Renovia Inc. (Renovia), a women-led company that develops digital therapeutics for female pelvic floor disorders, has launched a new brand campaign titled, Stronger Women, at the American College of Obstetricians and Gynecologists (ACOG) Annual Clinical & Scientific Meeting (ACSM). The campaign is intended to educate clinicians and women about urinary incontinence (UI) and the leva® Pelvic Health System, a convenient, easy-to-use, at-home pelvic health program that can help women strengthen their pelvic floor and decrease the symptoms of stress, mixed and mild to moderate UI, including overactive bladder. Through the campaign, and by launching it at the ACSM, Renovia seeks to make first-line treatment for UI more accessible and accelerate the momentum supporting regular screening for female UI among clinicians.

Key Points: 
  • The Stronger Women campaign centers on the importance of a strong pelvic floor in women's overall health and well-being.
  • The campaign also humanizes the issues associated with UI and, thus, seeks to make UI less taboo.
  • "While ACOG recommends annual screening for UI, treatment options often require drugs, surgery or access to physical therapy.
  • Renovia Inc. and levaare trademarks or registered trademarks of Renovia Inc. in the United States and other countries.

The Fibroid Foundation Announces Fibroid Summit 2022 - a Patient-Hosted Research Conference

Retrieved on: 
Tuesday, February 1, 2022
Legislation, Patient, Puberty, Tinelli, Publication, Obstetrics & Gynecology (journal), Human, Gynaecology, Woman, Research, Reproductive health, Man, Biomedical Research, Fibroid, Menopause, Health, Education, Hope, Medicine, Birth control, Obstetrics

This year will be the second year of the Fibroid Summit, and we can't wait to engage with our community," said Fibroid Foundation Founder and CEO Sateria Venable.

Key Points: 
  • This year will be the second year of the Fibroid Summit, and we can't wait to engage with our community," said Fibroid Foundation Founder and CEO Sateria Venable.
  • The Fibroid Foundation includes 26 chapters and a readership of 32,000 people globally.
  • The Campion Fund was founded to promote basic biomedical research on diseases that affect the human reproductive system.
  • Through medical research and education, The Campion Fund works to eradicate diseases, and to restore health and hope to women and men worldwide.